Dianthus Platform: Screening for Modulators of STING
The adaptor protein STING (stimulator of interferon genes) has emerged as an exciting target for both immunological conditions (STING inhibition) and cancer therapies (STING activation). To support drug discovery teams in the discovery of novel modulators of STING, WuXi AppTec offers an integrated platform of ready-to-go biophysical assays and Dianthus, a plate-based and microfluidics-free affinity screening platform providing high quality data. Leverage our expertise now to accelerate your STING research!
Dianthus STING
Related Content
At the 2024 Protein & Antibody Engineering Summit (PEGS) Europe, Crelux presented a poster highlighting its drug discovery platform for...
VIEW RESOURCEThe ErbB family of receptor tyrosine kinases are involved in key cellular functions, including cell growth and survival. ErbB family...
VIEW RESOURCE